Clinical Trial Update: ZETAMET™ BONE GRAFT IN THE REPAIR OF BONE DEFECTS FROM METASTATIC BREAST CANCER IN VERTEBRAL BONES [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ZETAMET Bone Graft in repairing vertebral bone defects caused by metastatic breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Breast Cancer

Drugs mentioned

• ZETAMET Bone Graft

Snippet

Sponsor: Zetagen Therapeutics, Inc | Conditions: Metastatic Breast Cancer in the Spine | Phase 2 | Status: COMPLETED